ArticleMolecules (Basel, Switzerland)2022

Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis.

Santo Previti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.